Skip to main content
. 2016 Dec 21;25(3):308–314. doi: 10.1038/ejhg.2016.182

Table 1. List of patients with causative variants in HI-related genes.

Patient Gene, Ref Seq transcript ID Variant 1 nucleotide change (protein change) Variant 2 nucleotide change (protein change) Zygositya Segregating with HIb
AD1c MYO6 NM_004999.3 c.1546+1G>T (p.?) - het Yes
AD2 WFS1 NM_006005.3 c.2051C>T (p.(Ala684Val))c - het ND
AD3 TECTA ENST00000392793.1 c.6002G>T (p.(Cys2001Phe)) - het de novo
AD4 MYO7A NM_000260.3 c.1373A>T (p.(Asn458Ile))c - het Yes
AD5c MYO6 NM_004999.3 c.1211del (p.(Gly404Glufsa4)) - het Yes
AD6c MYH9 NM_002473.5 c.2507C>T (p.(Pro836Leu)) - het Yes
AD7 POU4F3 NM_002700.2 c.828_829insT (p.(Lys277a)) - het ND
AD8 MYO7A NM_000260.3 c.652G>A (p.(Asp218Asn)) - het Yes
AD9 POU4F3 NM_002700.2 c.668T>C (p.(Leu223Pro))c - het ND
AD10 MYO6 NM_004999.3 c.3395del (p.(Lys1132Serfsa12)) - het Yes
AD11 SOX10 NM_006941.3 c.1195C>T (p.(Gln399a)) - het ND
AD12 MITF NM_000248.3 c.649del (p.(Arg217Aspfsa4))c - het Yes
AD13 MYO7A NM_000260.3 c.2617C>T (p.(Arg873Trp))c - het Yes
AD14 TECTA ENST00000392793.1 c.5794A>C (p.(Thr1932Pro)) - het Yes
AD15 MYH14 NM_001145809.1 c.5176C>T (p.(Arg1726Trp)) - het Yes
AD16 WFS1 NM_006005.3 c.2032T>C (p.(Trp678Arg)) - het Yes
AD17 MYO6 NM_004999.3 c.584C>A (p.(Ala195Glu)) - het Yes
AD18 TECTA ENST00000392793.1 c.5597C>T (p.(Thr1866Met))c - het Yes
AR1c USH2A NM_206933.2 c.(9371+1_9372-1)_(9570+1_9571-1)del (p.?) c.(9371+1_9372-1)_(9570+1_9571-1)del (p.?) hom ND
AR2 OTOA ENST00000388958 c.(?_-1)_(a1_?)delc c.(?_-1)_(a1_?)delc hom ND
AR3c CIB2 NM_006383.3 c.97C>T (p.(Arg33a)) c.196C>T (p.(Arg66Trp)) compound het Yes
AR4 STRC NM_153700.2 c.(?_-1)_(a1_?)delc c.(?_-1)_(a1_?)delc hom Yes
AR5 USH2A NM_206933.2 c.(8845+1_8846-1)_(9371+1_9372-1)del (p.?) c.(8845+1_8846-1)_(9371+1_9372-1)del (p.?) hom Yes
AR6 TMC1 NM_138691.2 c.646del (p.(Leu216Serfsa54)) c.790C>T (p.(Arg264a)) ND ND
AR7 CDH23 NM_022124.5 c.6442G>A (p.(Asp2148Asn))c c.1545_1547del (p.(Ile515del))c compound het ND
AR8 USH2A NM_206933.2 c.1606T>C (p.(Cys536Arg))c c.9815C>T (p.(Pro3272Leu))c compound het Yes
AR9 GJB2 NM_004004.5 c.35del (p.(Gly12Valfsa2))c c.71G>A (p.Trp24a))c ND ND
AR10 GJB2 NM_004004.5 c.35del (p.(Gly12Valfsa2))c c.35del (p.(Gly12Valfsa2))c hom ND
AR11 CDH23 NM_022124.5 c.2096A>G (p.(Asp699Gly)) c.4562A>G (p.(Asn1521Ser)) compound het Yes
AR12 GJB2 NM_004004.5 c.-23+1G>A (p.?)c c.35del (p.(Gly12Valfsa2))c compound het ND
AR13 MYO7A NM_000260.3 c.3289C>T (p.(Gln1097a)) c.3862G>C (p.(Ala1288Pro))c compound het ND
      c.5227C>T (p.Arg1743Trp)c    
AR14 STRC NM_153700.2 c.(?_-1)_(a1_?)delc c.(?_-1)_(a1_?)delc hom ND
AR15 PCDH15 NM_033056.3 c.3374-2A>G (p.?) c.4127C>A (p.(Ala1376Asp)) compound het Yes
AR16 STRC NM_153700.2 c.(?_-1)_(a1_?)delc c.(?_-1)_(a1_?)delc hom ND
AR17 LOXHD1 NM_144612.6 c.1618dup (p.(Thr540Asnfsa24)) c.1730T>G (p.(Leu577Arg)) compound het Yes
AR18 USH2A NM_206933.2 c.5018T>C (p.(Leu1673Pro)) c.2299del (p.(Glu767Serfsa21)) compound het ND
    c.7871C>T (p.(Pro2624Leu))      
ISO1c MYO15A NM_016239.3 c.625G>T (p.(Glu209a)) c.1137del (p.(Tyr380Metfsa64))c ND ND
ISO2c USH2A NM_206933.2 c.5385T>A (p.(Tyr1795a)) c.6846_6849dup (p.(His2284Asnfsa48)) ND ND
ISO3 CDH23 NM_022124.5 c.8480_8481del (p.(Leu2827Hisfsa23)) c.8480_8481del (p.(Leu2827Hisfsa23)) hom ND
ISO4c MYO15A NM_016239.3 c.6764+2T>A (p.?) c.3844C>T (p.(Arg1282Trp) ND ND
      c.5287C>T (p.(Arg1763Trp))    
ISO5 GJB2 NM_004004.5 c.101T>C (p.(Met34Thr))17 c.109G>A (p.(Val37Ile))17 compound het ND
ISO6 WFS1 NM_006005.3 c.2051C>T (p.(Ala684Val))2 - het ND
ISO7 MYO15A NM_016239.3 c.6787G>A (p.(Gly2263Ser)) c.7893+1G>A (p.?) compound het ND
ISO8 TRIOBP NM_001039141.2 c.2653del (p.(Arg885Alafsa120)) c.5014G>T (p.(Gly1672a)) compound het ND
ISO9 USH2A NM_206933.2 c.2299del (p.(Glu767Serfsa21)) c.920_923dup (p.(His308Glnfsa16)) compound het ND
ISO10 MYO7A NM_000260.3 c.3476G>T (p.(Gly1159Val))c c.5560G>A (p.Val1854Met))c compound het ND
ISO11 GJB2 NM_004004.5 c.250G>C(p.(Val84Leu)) c.269T>C (p.(Leu90Pro))c ND ND
ISO12 GJB2 NM_004004.5 c.109G>A (p.(Val37Ile))c c.109G>A (p.(Val37Ile))c hom ND
ISO13 TMPRSS3 NM_024022.2 c.916G>A (p.(Ala306Thr))c c.1276G>A (p.(Ala426Thr))c ND ND
ISO14 STRC NM_153700.2 c.(?_-1)_(a1_?)delc c.(?_-1)_(a1_?)delc hom ND
ISO15 GJB2 NM_004004.5 c.35del (p.(Gly12Valfsa2))c c.101T>C (p.(Met34Thr))c compound het ND
ISO16 ACTG1 NM_001199954.1 c.773C>T (p.(Pro258Leu)) - het de novo
ISO17 GJB2 NM_004004.5 c.35del (p.(Gly12Valfsa2))c c.508_511dup p.Ala171Glufsa40))c compound het ND
ISO18 MYO15A NM_016239.3 c.3311dup (p.(Glu1105a)) c.3311dup (p.(Glu1105a)) hom ND
ISO19 TRIOBP NM_001039141.2 c.3460_3461del (p.(Leu1154Alafsa29)) c.3232dup (p.(Arg1078Profsa6))c compound het ND
ISO20 MYO7A NM_000260.3 c.5618G>A (p.(Arg1873Gln))c c.6028G>A (p.(Asp2010Asn))c compound het ND
ISO21 MYO6 NM_004999.3 c.3610C>T (p.(Arg1204Trp))c - het de novo
ISO22 SLC26A5 NM_198999.2 c.355C>T (p.(Pro119Ser)) c.355C>T (p.(Pro119Ser)) hom ND
ISO23 GJB2 NM_004004.5 c.101T>C (p.(Met34Thr))c c.109G>A (p.(Val37Ile))c compound het ND
ISO24 SOX10 NM_006941.3 c.482G>A (p.(Arg161His))c - het de novo
ISO25 MYO6 NM_004999.3 c.3335A>G (p.(Tyr1112Cys)) c.1897del (p.(Gln633Lysfsa19)) compound het ND
ISO26 LARS2 NM_015340.3 c.683G>A (p.(Arg228His)) c.880G>A (p.(Glu294Lys)) compound het ND
ISO27 OTOA ENST00000388958 c.(?_-1)_(a1_?)delc c.(?_-1)_(a1_?)delc hom ND
ISO28c COL11A1 NM_001854.3 c.1630-2del (p.?) - het ND
ISO29 LOXHD1 NM_144612.6 c.3061+1G>A (p.?) c.6353G>A (p.(Gly2118Glu)) ND ND
ISO30 LOXHD1 NM_144612.6 c.3061C>T (p.(Arg1021a)) c.5885C>T (p.(Thr1962Met)) compound het ND
ISO31 SLC26A4 NM_000441.1 c.505del (p.(Thr169Leufsa3)) c.1334T>G (p.(Leu445Trp))c compound het ND

Abbreviations: AD, autosomal dominant; AR, autosomal recessive; het, heterozygous; HI, hearing impairment; hom, homozygous; ISO, isolated; ND, not determined or not conclusive.

a

Zygosity, determined on basis of segregation analysis in the parents.

b

Segregating with HI, determined on basis of segregation analysis in affected and/or unaffected family members.

c

Mutations that have been described in literature before, the corresponding references are provided in Supplementary Table S2.